We have shown previously that Escherichia coli cells constructed to lack both thioredoxin and glutaredoxin are not viable unless they also acquire an additional mutation, which we called X. Here we show that X is a cysA mutation. Our data suggest that the inviability of a trxA grx double mutant is due to the accumulation of 3'-phosphoadenosine 5'-phosphosulfate (PAPS), an intermediate in the sulfate assimilation pathway. The presence of excess cystine at a concentration sufficient to repress the sulfate assimilation pathway obviates the need for an X mutation and prevents the lethality of a novel cys+ trxA grx double mutant designated strain A522. Mutations in genes required for PAPS synthesis (cysA or cysC) protect cells from the otherwise lethal effect of elimination of both thioredoxin and glutaredoxin even in the absence of excess cystine. Both thioredoxin and glutaredoxin have been shown to be hydrogen donors for PAPS reductase (cysH) in vitro (M. L.-S. Tsang, J.
We have shown previously that Escherichia coli cells constructed to lack both thioredoxin and glutaredoxin are not viable unless they also acquire an additional mutation, which we called X. Here we show that X is a cysA mutation. Our data suggest that the inviability of a trxA grx double mutant is due to the accumulation of 3'-phosphoadenosine 5'-phosphosulfate (PAPS), an intermediate in the sulfate assimilation pathway. The presence of excess cystine at a concentration sufficient to repress the sulfate assimilation pathway obviates the need for an X mutation and prevents the lethality of a novel cys+ trxA grx double mutant designated strain A522. Mutations in genes required for PAPS synthesis (cysA or cysC) protect cells from the otherwise lethal effect of elimination of both thioredoxin and glutaredoxin even in the absence of excess cystine. Both thioredoxin and glutaredoxin have been shown to be hydrogen donors for PAPS reductase (cysH) in vitro (M. L.-S. Tsang, J. Bacteriol. 146:1059-1066, 1981), and one or the other of these compounds is presumably essential in vivo for growth on minimal medium containing sulfate as the sulfur source. The cells which lack both thioredoxin and glutaredoxin require cystine or glutathione for growth on minimal medium but maintain an active ribonucleotide reduction system. Thus, E. coli must contain a third hydrogen donor active with ribonucleotide reductase.
Thioredoxin and glutaredoxin are small, heat-stable, redox-active proteins that have been isolated as hydrogen donors for ribonucleotide diphosphate reductase, an essential Escherichia coli enzyme that reduces ribonucleotides to deoxyribonucleotides (17, 18, 28) . Glutaredoxin was discovered in a mutant of E. coli that lacked thioredoxin (trxA) (14) ; it has glutathione (GSH)-disulfide transhydrogenase activity (15, 16) which enables GSH to serve as a hydrogen donor for ribonucleotide reductase. Glutaredoxin, with 85 amino acid residues, has essentially no similarity in primary structure to thioredoxin, with 108 amino acid residues (13, 19) ; however, both of these proteins have a 14-member disulfide ring in the active center with the sequence -CXYC-, and it has been suggested that they have similar three-dimensional structures (2) .
Glutaredoxin is markedly less abundant than thioredoxin (15) , but it shows a lower Km for ribonucleotide reductase (16) , and it has been presumed that either glutaredoxin is the actual in vivo cofactor or glutaredoxin can substitute for thioredoxin in vivo as well as in vitro (17) . Thioredoxin and glutaredoxin can participate in the following reactions as well (10) : in the reduction of sulfate to sulfite by 3'-phosphoadenosine 5'-phosphosulfate (PAPS) reductase (29) , an enzyme of the sulfate assimilation pathway leading to cysteine synthesis, and in the reduction of methionine sulfoxide to methionine by methionine sulfoxide reductases (5) . Only in the latter case has the in vivo hydrogen donor been established; an E. coli methionine-requiring mutant cannot utilize exogenous methionine sulfoxide if it lacks thioredoxin, showing that thioredoxin is the main reductant (26) .
Recently, we constructed a glutaredoxin null mutant (grx::kan) which grew as well as its wild-type parent under all conditions tested (25) . Our initial efforts to isolate a strain lacking both thioredoxin and glutaredoxin failed, suggesting that one or the other of these proteins is required for * Corresponding author.
viability. However, we finally succeeded in constructing such a strain; genetic data indicated that this AtrxA grx::kan mutant, designated strain A410, was not viable until an additional mutation, which we referred to as X, had arisen. In this paper we show that X is a cysA mutation. We present data that suggest that the inviability of the AtrxA grx::kan mutant is due to the accumulation of an intermediate in the sulfate assimilation pathway, PAPS. The presence of cystine at a concentration sufficient to inhibit the pathway, as well as mutations in genes required for PAPS synthesis (cysA or cysC), protects cells from the otherwise lethal effect of elimination of both thioredoxin and glutaredoxin.
Strains that lack thioredoxin and glutaredoxin maintain an active ribonucleotide reduction system. Thus, E. coli must contain a third hydrogen donor active with ribonucleotide reductase.
MATERIALS AND METHODS
Bacterial strains, media, and genetic techniques. The bacterial strains used in this study are listed in Table 1 . P1 transductions were done as described previously (23, 25) , and cotransduction of linked markers was determined by replica plating unless otherwise indicated. Transformation of cells, growth media, and plating of cells were as previously described (25, 26) . Either cystine or cysteine satisfied the growth requirements of the mutants used in this study; cystine was used routinely. Tetracycline-sensitive cells were selected by the method of Maloy and Nunn (22) .
As noted previously, strain A410 cells grow on minimal medium to which methionine (50 ,ug/ml) is added. This was seen also for an established cysA mutant and is a result that was obtained independently in both of our laboratories. This result is not in accord with presently known metabolic pathways in E. coli but has been observed previously (20) . Contamination of the methionine with cystine or cysteine might account for this result. Alternatively, conversion of methionine to cysteine as in eucaryotic cells could conceivably occur.
Preparation of extracts and in vitro assays. Cultures of strains A407, A408, and A410 were grown at 37°C with shaking in 500 ml of FB medium (25) . The cells were harvested in log phase at an A650 of about 0.7 and were frozen at -20°C overnight. Fresh cleared lysates of gently lysed cells were prepared by treatment with lysozyme and osmotic shock of spheroplasts, followed by high-speed centrifugation. The activity of ribonucleotide reductase in the extract was determined with [3H]CDP and NADPH, essentially as previously reported (14) .
Log-phase cells (A650, 0.7) from 200-ml cultures were also permeabilized with ether as described by Warner (30) and were assayed for endogenous ribonucleotide reductase activity with [3H]CDP and dithiothreitol (final concentration, 40 mM). The cell suspensions (1010 cells per ml) were stored frozen at -70°C.
RESULTS
Properties of the mutant strains. The properties of E. coli A410, which lacks thioredoxin and glutaredoxin, are sum- Table 2 . Because A410 has several puzzling phenotypes (mucoidy and a cell separation defect) in addition to the cysteine requirement, a second derivative was isolated by transducing thioredoxin deletion strain A307 with a zbi::TnlO grx::kan P1 lysate and selecting on rich (Ty) plates, as described previously (25) . The properties of this strain, A410-2, are also presented in Table 2 , along with the properties of parental control strains A307 (AtrxA), A407 (grx::kan zbi::TnlO), and A408 (zbi::TnlO). The three control strains grew on defined medium in the absence of amino acids, while A410 and A410-2 did not. Addition of cystine, cysteine, or glutathione enabled these strains that lack thioredoxin and glutaredoxin to grow. Strain A410 formed filaments of septated, but unseparated cells, and the colonies that it produced were mucoid, especially on minimal medium. In contrast, A410-2 formed neither filaments nor mucoid colonies. The basis for these differences is not understood, but these properties are not obligatorily coupled to the survival of AtrxA grx::kan cells. Additional AtrxA grx: :kan transductants, which, like A410, were derived from strain K38, also required cystine for growth; this requirement was not a fortuitous result of mutations present in the K38 background (Table 1) , since AtrxA grx::kan derivatives of strain W3110 also had a cystine requirement (data not shown).
To determine whether the inability of A410 and A410-2 to grow on defined medium without a reduced sulfur source is a physiological consequence of having neither thioredoxin nor glutaredoxin or whether it reflects a genetic change, thioredoxin or glutaredoxin or both were restored. Introduction of the wild-type trxA gene on a high-copy-number plasmid did not eliminate the requirement, nor did it alter the cell separation or mucoidy phenotypes of A410 derivatives ( Table 3 ). The wild-type genes were also restored by P1 transduction (Fig. 1) . Introduction of the wild-type grx gene (and elimination of the mutant allele) into A410 did not alter these properties, but replacement of the AtrxA allele by transduction to trxA + eliminated the cell separation defect of A410 (Table 3 ). This suggests that the cell separation defect is genetically, but not functionally, linked to the AtrxA allele. The derivatives of A410 and A410-2 which carried trxA+ or grx+ or both still required cystine for growth. Thus, the inability of parental strains A410 and A410-2 to grow without cystine reflects a genetic change.
A trxA gshA double mutant, strain A397, which lacked thioredoxin and glutathione synthase, also required cystine and showed a growth defect even in rich medium (Table 3 ) (7); in contrast to the results obtained with mutants that lacked thioredoxin and glutaredoxin, restoration of thiore- (26) .
doxin reversed the cystine requirement and cured the growth defect of A397 (Table 3 ) (7). Characterization of the cystine requirement in AtrxA grx::kan mutants. Strain A410 cells grew on sulfite as a sulfur source, which is consistent with a block in sulfate conversion to PAPS via the known metabolic reactions in the cysteine biosynthetic pathway (Fig. 2) . Gillespie et al. (9) reported that cysH mutants of Salmonella typhimurium, which were blocked in the reduction of PAPS, accumulated secondary mutations in cysA, cysC, and cysD, genes involved in steps in cysteine biosynthesis that precede the reaction controlled by cysH (Fig. 2) Inhibition of PAPS synthesis enables AtrxA grx::kan mutants to survive. The sulfate assimilation pathway is subject to feedback inhibition by cyst(e)ine (20) . If the lethality due to the absence of thioredoxin and glutaredoxin is due to PAPS accumulation, cyst(e)ine at high concentration should inhibit the pathway and eliminate the lethality. Table 4 shows that this is the case. The zbi::TnJO and grx::kan mutations are very closely linked; as shown previously, almost all of the Tetr transductants of a trxA+ strain become grx::kan. When transductants were selected on defined medium containing 0.1% Casamino Acids (conditions permissive for cysA and cysC mutants), the number of Tetr transductants of AtrxA strain A307 was low with the zbi::TnJO grx::kan donor (compared with the control transduction with a zbi::TnJO grx+ donor), and none of the transductants became grx::kan. This linkage distortion confirmed our previous observation that AtrxA grx: :kan mutant strains are not viable under these conditions (25) . However, when Tetr transductants of AtrxA strain A307 were selected on the same defined medium that contained additional cystine (15 p.g/ml), normal linkage was restored. One of these new AtrxA grx: :kan transductants was saved as strain A522. Although this strain also tended to accumulate bettergrowing derivatives, it was genetically cys+ even though it required high concentrations of cystine for growth; unlike what happened with A410, when thioredoxin or glutaredoxin was restored to A522 (by introducing the genes on a plasmid), A522 grew in the absence of cystine (data not shown). Presumably, while the cystine concentration in 0.1% Casamino Acids is sufficient to support growth of a cys mutant, it is not sufficient to inhibit the sulfate assimilation pathway. Similar results were obtained with a AtrxA derivative of strain W3110 (data not shown).
To further test the idea that accumulation of a toxic intermediate is lethal to cells that lack thioredoxin and glutaredoxin, a AtrxA cysC double mutant strain was constructed, and this strain was transduced to Tetr (without excess cystine) by using the zbi::TnJO and zbi::TnJO grx: :kan donors. The cysC mutation protected trxA grx mutant cells ( donor was used, and most of the transductants had become grx::kan. The protective effect of a cysC mutation, which blocks the conversion of adenosine 5'-phosphosulfate to PAPS (Fig. 2) (25) . This result was consistent with the total absence of both thioredoxin and glutaredoxin, which was also demonstrated by using a radioimmunoassay. Furthermore, it was consistent with the absence of any major heat-stable hydrogen donor activity that could be reduced either by GSH and glutathione reductase or by thioredoxin reductase. To test whether E. coli A410 cells had active ribonucleotide reductase, either ether-treated cells or high-speed supematants were used. The ether-permeabilized cells all had active ribonucleotide reductase when they were assayed with a high dithiothreitol concentration (Table 6 ). Thus, they contained an active ribonucleotide reductase system, whether or not thioredoxin or glutaredoxin or neither was present.
High-speed supernatants of lysozyme-lysed, exponentially growing E. coli cells contain a labile, high-activity form 5 ,ug of thiamine per ml, and 0.1% Casamino Acids with or without additional cystine (0.062 mM).
b CAA, Casamino Acids. phage lysates prepared on strain A408 (zbi::TnIO) or on strain A407 (zbi::TnIO grx: :kan). Tetracycline-resistant transductants were selected on minimal plates containing 0.2% glucose, 5 ,ug of thiamine per ml, and 0.1% Casamino Acids; cotransduction of grx::kan was determined by picking transductants onto plates that contained kanamycin and tetracycline. b After several days of incubation at 37°C, additional, very small colonies appeared on the selective plates; they were Tetr Kanr cys.
of ribonucleotide reductase when they are assayed with NADPH and dithiothreitol as the ultimate hydrogen donors (3) or with only NADPH (14) . The wild-type and mutant extracts gave similar activities with NADPH as the ultimate hydrogen donor (Table 7) ; if anything, the mutant (A410) lacking both thioredoxin and glutaredoxin was more active in ribonucleotide reduction, strongly suggesting that an unknown third hydrogen donor was present.
DISCUSSION
The construction of a double mutant without thioredoxin and glutaredoxin would a priori be expected to result in a strain without functional ribonucleotide reductase, an essential enzyme (6) (7) (8) 28) . Quite unexpectedly, we found previously (25) that we could obtain a double mutant (A410) but that it had to acquire a compensating mutation, X, before it could grow. Since strain A410 cells can grow on glucose minimal medium to which only glutathione, cystine, or methionine has been added, they must be using endogenous nucleotides and thus be dependent on ribonucleotide reduc- (30) and stored at -70°C before they were assayed in a final volume of 125 p.1 cpm/nmol), and 40 mM dithiothreitol. The preparations were incubated at 37°C for 20 min, and dCDP levels were determined (14) . and a role for cystine as a negative regulator of the PAPS biosynthesis pathway (20) .
With respect to ribonucleotide reductase, there must be a third hydrogen donor system even in nonmutant cells. However, glutaredoxin and thioredoxin are likely to be important for ribonucleotide reduction in normal cells. Support for this hypothesis comes from studies of DNA metabolism in bacteriophage T4. T4 encodes a ribonucleotide reductase and a thioredoxin (28) . T4 thioredoxin is homologous to E. coli glutaredoxin in structure (2, 19) and has glutaredoxin activity by catalyzing GSH-dependent reduction of T4 ribonucleotide reductase; it is also a substrate for E. coli thioredoxin reductase and therefore maximizes the transfer of reducing equivalents to T4 DNA precursor synthesis (17) .
Ribonucleotide reduction in E. coli is more complex than has hitherto been thought. The ribonucleotide reductase encoded by the nrdA and nrdB genes was defined as essential by the isolation of nrd mutants that are not viable at high temperatures (6) (7) (8) . Hantke (12) has recently isolated E. coli mutants with large insertions in nrdB; these mutants grow anaerobically and, if depleted of iron, aerobically. Barlow (1) has found that a temperature-sensitive nrdA nrdB double mutant grows anaerobically at the nonpermissive temperature even in the presence of hydroxyurea, an inhibitor of the tyrosyl radical-containing nrdB-encoded B2 subunit. Furthermore, an oxygen-sensitive new ribonucleoside triphosphate reductase activity has been discovered in anaerobically grown E. coli by Fontecave et al. (4) .
The reactions in which thioredoxin and glutaredoxin are known to participate are shown in Fig. 3 . For most purposes the two proteins can substitute for each other. The reduction of methionine sulfoxide is specifically dependent on thioredoxin in vivo (26) , but if increased levels of glutaredoxin are provided from a high-copy-number plasmid, slow growth of a methionine auxotroph on methionine sulfoxide can be obtained (unpublished data). Both ribonucleotide reduction and sulfate reduction are essential reactions in E. coli grown on minimal medium containing sulfate; without the first reaction no DNA synthesis is possible, and without the second no synthesis of proteins or coenzymes with reduced sulfur (coenzyme A, biotin, lipoic acid, etc.) would occur. Since either a trxA mutant or a grx mutant is viable, thioredoxin and glutaredoxin can replace each other in sulfate reduction reactions; however, one of the two is essential. Ribonucleotide reduction, either aerobically or anaerobically (25) , can occur in the absence of these proteins. Thus, a third hydrogen donor for ribonucleotide reduction exists. In this paper we present evidence that there is an NADPH-linked system in crude extracts that remains to be characterized. It is possible that this third hydrogen donor is coupled with either the activity found in anaerobically grown cells (1, 4) or the classical nrd-encoded ribonucleotide reductase.
